|
1
|
Chintagumpala M, ChevezBarrios P, Paysse
EA, Plon SE and Hurwitz R: Retinoblastoma: Review of current
management. Oncologist. 12:1237–1246. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Houston SK, Murray TG, Wolfe SQ and
Fernandes CE: Current update on retinoblastoma. Int Ophthalmol
Clin. 51:77–91. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Devesa SS: The incidence of
retinoblastoma. Am J Ophthalmol. 80:263–265. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tamboli A, Podgor MJ and Horm JW: The
incidence of retinoblastoma in the United States: 1974 through
1985. Arch Ophthalmol. 108:128–132. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Francis JH, Brodie SE, Marr B, Zabor EC,
MondesireCrump I and Abramson DH: Efficacy and toxicity of
intravitreous chemotherapy for retinoblastoma: Fouryear experience.
Ophthalmology. 124:488–495. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Beijing Pharmaceutical Industry Research
Institute, . Active ingredient research of Chuanxiong: I.
Extraction, isolation and structural identification of
ligustrazine. Natl Med J Chin. 7:420–421. 1977.(In Chinese).
|
|
7
|
China Food and Drug Administration.
http://app1.sfda.gov.cn/datasearch/face3/base.jsp?tableId=25&tableName=TABLE25&title=%B9%FA%B2%FA%D2%A9%C6%B7&bcId=124356560303886909015737447882June
22–2019
|
|
8
|
You JM, Zhang ZG, Lin C and Ji Y: Ischemic
stroke and the regulation of syndrome of traditional Chinese
medicine compound efficacy TMP combined. Chin Archives of Tradit
Chin Med. 12:2666–2668. 2010.(In Chinese).
|
|
9
|
Tang Z, Wang S and Lin Y: Progress in
protective effects of tetramethylpyrazine on diabetes complications
in nervous system and possible mechanisms. Chin J Pharmacol
Toxicol. 25:114–118. 2011.(In Chinese).
|
|
10
|
Chen Y and Liu M: Systemic evaluation of
Security of ligustrazine for treatment of cerebral infarction. Chin
J Clin Rehab. 07:1299–1301. 2004.(In Chinese).
|
|
11
|
Yang XG and Jiang C: Ligustrazine as a
salvage agent for patients with relapsed or refractory
non-Hodgkin's lymphoma. Chin Med J (Engl). 123:3206–3211. 2010.(In
Chinese). PubMed/NCBI
|
|
12
|
Chen Z, Pan X, Georgakilas AG, Chen P, Hu
H, Yang Y, Tian S, Xia L, Zhang J, Cai X, et al:
Tetramethylpyrazine (TMP) protects cerebral neurocytes and inhibits
glioma by down regulating chemokine receptor CXCR4 expression.
Cancer Lett. 336:281–289. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu J and Li Q: Effect of
tetramethypyrazine on the proliferation and apoptosis of lung
cancer cell line of a549 and its mechanism. Med J Wuhan Univ.
3:50–51. 2010.(In Chinese).
|
|
14
|
Lu X, Wang Z and Chen J:
Tetramethylpyrazine induced expression of iNOS and NO to inhibit
lung metastasis of melanoma bearing mice. Chin J Mod Med.
16:3208–3210. 2006.(In Chinese).
|
|
15
|
Hua Z and Zhou Y: TMP inhibits the
proliferation of gastric carcinoma cells and endothelial cells. J
Changchun Univ Tradit Chin Med. 25:20–22. 2009.(In Chinese).
|
|
16
|
Wang S, Lei T and Zhang M: The reversal
effect and its mechanisms of Tetramethylpyrazine on multidrug
resistance in human bladder cancer. PLoS One. 11:e01577592016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Y, Liu X, Zuo T, Liu Y and Zhang JH:
Tetramethylpyrazine reverses multidrug resistance in breast cancer
cells through regulating the expression and function of
P-glycoprotein. Med Oncol. 29:534–538. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang XB, Wang SS, Zhang QF, Liu M, Li HL,
Liu Y, Wang JN, Zheng F, Guo LY and Xiang JZ: Inhibition of
tetramethylpyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug
resistant human hepatocellular carcinoma cells. Oncol Rep.
23:211–215. 2010.PubMed/NCBI
|
|
19
|
Wu N, Xu L, Yang Y, Yu N, Zhang Z, Chen P,
Zhang J, Tang M, Yuan M, Ge J, et al: Tetramethylpyrazinemediated
regulation of CXCR4 in retinoblastoma is sensitive to cell density.
Mol Med Rep. 15:2481–2488. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Su L, Zhang J, Xu H, Wang Y, Chu Y, Liu R
and Xiong S: Differential expression of CXCR4 is associated with
the metastatic potential of human non-small cell lung cancer cells.
Clin Cancer Res. 11:8273–8280. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Smith MC, Luker KE, Garbow JR, Prior JL,
Jackson E, PiwnicaWorms D and Luker GD: CXCR4 regulates growth of
both primary and metastatic breast cancer. Cancer Res.
64:8604–8612. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schrader AJ, Lechner O, Templin M, Dittmar
KE, Machtens S, Mengel M, ProbstKepper M, Franzke A, Wollensak T,
Gatzlaff P, et al: CXCR4/CXCL12 expression and signalling in kidney
cancer. Br J Cancer. 86:1250–1256. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liang Z, Brooks J, Willard M, Liang K,
Yoon Y, Kang S and Shim H: CXCR4/CXCL12 axis promotes VEGFmediated
tumor angiogenesis through Akt signaling pathway. Biochem Biophys
Res Commun. 359:716–722. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou Y, Larsen PH, Hao C and Yong VW:
CXCR4 is a major chemokine receptor on glioma cells and mediates
their survival. J Biol Chem. 277:49481–49487. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Müller A, Homey B, Soto H, Ge N, Catron D,
Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, et al:
Involvement of chemokine receptors in breast cancer metastasis.
Nature. 410:50–56. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yin X, Liu Z, Zhu P, Wang Y, Ren Q, Chen H
and Xu J: CXCL12/CXCR4 promotes proliferation, migration, and
invasion of adamantinomatous craniopharyngiomas via PI3K/AKT signal
pathway. J Cell Biochem. 120:9724–9736. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jung SJ, Kim CI, Park CH, Chang HS, Kim
BH, Choi MS and Jung HR: Correlation between chemokine receptor
CXCR4 expression and prognostic factors in patients with prostate
cancer. Korean J Urol. 52:607–611. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Spoo AC, Lübbert M, Wierda WG and Burger
JA: CXCR4 is a prognostic marker in acute myelogenous leukemia.
Blood. 109:786–791. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Z, Ni C, Chen W, Wu P, Wang Z, Yin
J, Huang J and Qiu F: Expression of CXCR4 and breast cancer
prognosis: A systematic review and meta-analysis. BMC Cancer.
14:492014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yu N, Zhang Z, Chen P, Zhong Y, Cai X, Hu
H, Yang Y, Zhang J, Li K, Ge J, et al: Tetramethylpyrazine (TMP),
an active ingredient of chinese herb medicine Chuanxiong,
attenuates the degeneration of trabecular meshwork through
SDF1/CXCR4 axis. PLoS One. 10:e01330552015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cai X, Chen Z, Pan X, Xia L, Chen P, Yang
Y, Hu H, Zhang J, Li K, Ge J, et al: Inhibition of angiogenesis,
fibrosis and thrombosis by tetramethylpyrazine: Mechanisms
contributing to the SDF-1/CXCR4 axis. PLoS One. 9:e881762014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Uchida D, Onoue T, Begum NM, Kuribayashi
N, Tomizuka Y, Tamatani T, Nagai H and Miyamoto Y: Vesnarinone
downregulates CXCR4 expression via upregulation of Kruppel-like
factor 2 in oral cancer cells. Mol Cancer. 8:622009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Helbig G, Christopherson KW II,
Bhat-Nakshatri P, Kumar S, Kishimoto H, Miller KD, Broxmeyer HE and
Nakshatri H: NFkappaB promotes breast cancer cell migration and
metastasis by inducing the expression of the chemokine receptor
CXCR4. J Biol Chem. 278:21631–21638. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tang MJ, Yang Y, Yu JZ, Qiu J, Chen P, Wu
YH, Wang QY, Xu ZJ, Ge J, Yu K and Zhuang J: Tetramethylpyrazine in
a murine alkaliburn model blocks NFκB/NRF1/CXCR4-signaling-induced
corneal neovascularization. Invest Ophth Vis Sci. 59:2133–2141.
2018. View Article : Google Scholar
|
|
35
|
Moriuchi M, Moriuchi H, Margolis DM and
Fauci AS: USF/c-Myc enhances, while Yin-Yang 1 suppresses, the
promoter activity of CXCR4, a coreceptor for HIV-1 entry. J
Immunol. 162:5986–5992. 1999.PubMed/NCBI
|
|
36
|
Wegner SA, Ehrenberg PK, Chang G, Dayhoff
DE, Sleeker AL and Michael NL: Genomic organization and functional
characterization of the chemokine receptor CXCR4, a major entry
co-receptor for human immunodeficiency virus type 1. J Biol Chem.
273:4754–4760. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Schioppa T, Uranchimeg B, Saccani A,
Biswas SK, Doni A, Rapisarda A, Bernasconi S, Saccani S, Nebuloni
M, Vago L, et al: Regulation of the chemokine receptor CXCR4 by
hypoxia. J Exp Med. 198:1391–1402. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang Y, Wu N, Tian S, Li F, Hu H, Chen P,
Cai X, Xu L, Zhang J, Chen Z, et al: Lithium promotes DNA stability
and survival of ischemic retinal neurocytes by upregulating DNA
ligase IV. Cell Death Dis. 7:e24732016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using realtime quantitative PCR and
the 2(Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen P, Cai XX, Yang Y, Chen Z, Qiu J, Yu
N, Tang MJ, Wang QY, Ge J, Yu K and Zhuang J: Nuclear respiratory
factor-1 (NRF-1) regulates transcription of the CXC receptor 4
(CXCR4) in the rat retina. Invest Ophth Vis Sci. 58:4662–4669.
2017. View Article : Google Scholar
|
|
41
|
Chan JY, Kwong M, Lu R, Chang J, Wang B,
Yen TS and Kan YW: Targeted disruption of the ubiquitous CNC-bZIP
transcription factor, Nrf-1, results in anemia and embryonic
lethality in mice. EMBO J. 17:1779–1787. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chan JY, Cheung MC, Moi P, Chan K and Kan
YW: Chromosomal localization of the human NF-E2 family of bZIP
transcription factors by fluorescence in situ hybridization. Hum
Genet. 95:265–269. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
LeighBrown S, Enriquez JA and Odom DT:
Nuclear transcription factors in mammalian mitochondria. Genome
Biol. 11:2152010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Huo L and Scarpulla RC: Mitochondrial DNA
instability and peri-implantation lethality associated with
targeted disruption of nuclear respiratory factor 1 in mice. Mol
Cell Biol. 21:644–654. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang J, Gu JY, Chen ZS, Xing KC and Sun
B: Astragalus polysaccharide suppresses palmitate-induced apoptosis
in human cardiac myocytes: The role of Nrf1 and antioxidant
response. Int J Clin Exp Pathol. 8:2515–2524. 2015.PubMed/NCBI
|
|
46
|
Stetler RA, Leak RK, Yin W, Zhang LL, Wang
SP, Gao YQ and Chen J: Mitochondrial biogenesis contributes to
ischemic neuroprotection afforded by LPS pre-conditioning. J
Neurochem. 123 (Suppl):S125–S137. 2012. View Article : Google Scholar
|
